Navigation Links
The Female Health Company Schedules Second Quarter Conference Call for May 14, 2008
Date:5/7/2008

CHICAGO, May 7 /PRNewswire-FirstCall/ -- The Female Health Company (Amex: FHC) today announced that it will host an investor conference call to discuss its operating results for the second quarter of FY2008 at 11:00 a.m. Eastern Time (EDT) on Wednesday, May 14, 2008. The Company plans to report its second quarter FY2008 operating results earlier the same day.

Shareholders and other interested parties may participate in the conference call by dialing 800-860-2442 (international participants dial 412-858-4600) and asking to be connected to the Female Health Company Conference Call, a few minutes before 11:00 a.m. EDT on May 14, 2008. A replay of the call will be available one hour after the call through 5:00 pm on May 28, 2008 by dialing 877-344-7529 (international callers dial 412-317-0088) and entering the conference ID 418836.

About The Female Health Company

The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC Female Condom(R), which is primarily distributed by public health organizations and donor groups in over 90 developing countries around the world. World-wide, the Female Condom is available in various programs in 108 countries. The Company owns certain worldwide rights to the FC Female Condom(R), including patents that have been issued in the United States, United Kingdom, Japan, France, Italy, Germany, Spain, the European Patent Convention, the People's Republic of China, Canada, South Korea and Australia. FC Female Condom(R) is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy.

"Safe Harbor" statement under the Private Securities Litigation Reform
'/>"/>

SOURCE The Female Health Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. US Female Sterilization Market to Grow to Almost $245 Million Over the Next Five Years
2. Female vets face twice the fertility risk
3. Ingredient found in green tea significantly inhibits breast cancer growth in female mice
4. The Female Health Company Receives USAID DELIVER PROJECT Order for 6.1 Million Units
5. Correction: Therapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars
6. Photo: Beverly Hills Liposculpture Specializes in Scarless Breast Reduction Dr. Alan Bittner Reduces Female Breasts by up to 50%
7. The Female Health Company to Present at Growth and Value Investor Conference in Ft. Lauderdale
8. The Female Health Company Reports 37% Revenue Growth and Record Profits for First Quarter of FY2008
9. The Female Health Company Schedules First Quarter Conference Call for February 13, 2008
10. The Female Health Company Announces FDA Acceptance for Review of Its FC2 Premarket Approval Application
11. Psychotherapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...Renowned oncology researcher Dr. Daniel Von Hoff, ...Advisory Board, provides an in-depth look at "... trial design that creates rapid accrual rates, su...ings, enthusiasm from investigators and patients, ...nterview is available for download from Medelis, a...
(Date:7/9/2008)...9 /PRNewswire/ -- Tricom Document Management,(Tric...gement of legacy and,current documents for a globa...fic Data Centers, Inc. (PDC), a data processing bu...ents so that they can better focus on their,core c...he latest technological advances and,state-of-the-...
(Date:7/9/2008)...f uKarma,s vertical integration strategy and will,...lth and wellness brands, LOS ANGELES, July 9 /PRN...etin Board: UKMA), a lifestyle multimedia and cons...and personal development, announced today the,firs...a in October, 2008., Xflowsion, with its revoluti...
(Date:7/9/2008)...Contributing Editor, Judy Bachrach Launches Newly,... Terminally Ill and Those ...wire/ -- (ZealousPR) -- Today, http://www.thechec...n for,the terminally ill and those who are close t...new easily accessible FORUM for readers to discuss...
Breaking Medicine News(10 mins):Health News:Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit 2Health News:Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit 3Health News:Tricom Document Management Expands Onshore Services with Acquisition of Pacific Data Centers, Inc. 2Health News:uKarma to Open First Xflowsion Fitness Studio With Celebrity Trainer Eric Paskel 2Health News:Online Advice Column Receives Critical Acclaim; Baby Boomers Found Resourceful During Crisis 2
...experts have revealed that female foeticide is inc... mobile population of India. // The educated peopl...th, and poverty is not the only reason for these s...f selective abortions being made illegal in the co...
...hers belonging to the Yale School of Medicine have...regnant women are concerned can be diagnosed throu...ion in amniotic fluid. The chances of a premature ...ed through this process, according to the research...
... we know about the connection between age factor a...have found new proof that might establish this con...ng a study of baboons, it was discovered that as t...ncreased presence of old cells. It is well known t...
... from Pennsylvania school of medicine have found t...of severe stenosis or narrowed arteries in head ar.../ The result of the study conducted by Professor S...lished in the Journal Circulation. This new diag...
Other Medicine News:Health News:Link between Old Cells and Ageing probed 2
(Date:7/9/2008)... Research Has Set National Safety Standards, ...swire-USNewswire/ -- In a congressional,hearing Se...discussed the,safety and importance of the researc...Affairs (VA) as well as an absolute commitment to ...single veteran would feel improperly,treated or mi...
(Date:7/9/2008)... SAN DIEGO, July 9 /- ... announced positive results from a multiple-ascend...uate the compound,s safety,pharmacokinetics and p...overed oral drug candidate intended for the treatm...tions., The Phase 1b trial was a randomized, doub...
(Date:7/8/2008)... MAIDENHEAD, England, July 8 /PRNewswire-Firs...ldren Against the Leading,Vaccine-Preventable Caus...countries of Cyprus, Hungary, the Kingdom of,Bahra...n for announcing,their decisions to routinely immu...al disease by adding PREVENAR(TM) PCV7 (Pneumococc...
(Date:7/8/2008)... GLP-1 Has Potential to Treat Type 2 Diabetes U... Technology, CEDAR KNOLLS, N.J., July 8 /PR.... (Nasdaq: EMIS ) today announced findings from a...-1 peptide safely and effectively.,The study used ...Eligen(R),technology, and was conducted at Univers...
Breaking Medicine Technology:Secretary Reinforces VA's Commitment to Research Safety and Veteran Focus 2Secretary Reinforces VA's Commitment to Research Safety and Veteran Focus 3Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 2Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 3Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 4Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 5Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules 2Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules 3Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations 2Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations 3Benchmarking Study Report on Sales Performance Management 21730 1Benchmarking Study Report on Sales Performance Management 21730 2Consumers Urged to Avoid Raw Milk and Raw Milk Products 21727 1Derma Sciences CEO ED Quilty Discusses Company on BNN 21725 1Derma Sciences CEO ED Quilty Discusses Company on BNN 21725 2Abbott Opens New State of the Art R 26D Facility to Help Bring Medicines to Patients Faster 21722 1Abbott Opens New State of the Art R 26D Facility to Help Bring Medicines to Patients Faster 21722 2Abbott Opens New State of the Art R 26D Facility to Help Bring Medicines to Patients Faster 21722 3
... 2007 /PRNewswire/ -- Prolexys,Pharmaceuticals and...erties of the selective small molecule anti-tumor ...company,s,chemi-proteomics technology to understan... to be published in the June 14, 2007 issue,of the...hondrial,voltage- dependent anion channels (VDACs)...
...07 /PRNewswire/ -- Two studies presented,today dem... peak,plasma levels, nor did it impair middle-of-t...n patients who suffer from chronic,insomnia. The r...nnual Meeting of the Associated Professional Sleep...ause they show that ROZEREM may be,a safe sleep me...
Other Medicine Technology:Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 2Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 3Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 2Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 3Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 4Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 5
The Snellen chart remains to most popular chart design among clinicians. A range of different optotypes can be displayed in snellen format including British, sheridan-gardner, landolt Cs, tumbling Es
The PacScan 300AP is a portable, combination A-scan and pachymeter which provides easy-to-use touch screen operation. The combination of a high frequency, low noise probes and fast precise algorithms
Lightweight portable pachymeter, with compact LCD screen and optional printer. The Micropach 200P+ is extremely portable, weighing slightly more than 2 lbs (1 kg). The digital pachymeter provides a
16 segment Horizontal Prism bar provides 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 25, 30, 35, 40, 45 PD. 4446 xx Horizontal Prism Bar.
Medicine Products: